Cellino Raises $80m Series A To Transform Stem Cell Therapy Manufacturing

Leaps By Bayer Is Lead Investor

 
• By Andrew McConaghie
  
Nabiha Saklayen
CEO and co-founder, Nabiha Saklayen aims to have an automated 'cell foundry' up and running by 2025 • Source: Cellino
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip